GEHC - GE HealthCare
78.91
| Index: | NDX, S&P 500 | P/E: | 21.61 | EPS (ttm): | 3.65 | Insider Own: | 3.15% | Shs Outstand: | 456.85M | Perf Week: | -2.70% |
| Market Cap: | 36.74B | Forward P/E: | 16.88 | EPS next Y: | 4.67 | Insider Trans: | -0.18% | Shs Float: | 442.48M | Perf Month: | -7.06% |
| Income(ttm): | 1.68B | PEG: | 2.11 | EPS next Q: | 1.26 | Inst Own: | 80.96% | Short Float: | 1.96% | Perf Quarter: | -13.17% |
| Revenue(ttm): | 19.56B | P/S: | 1.88 | EPS this Y: | 9.32% | Inst Trans: | 6.42% | Short Ratio: | 2.65 | Perf Half Y: | 0.08% |
| Book/sh: | 18.20 | P/B: | 4.33 | EPS next Y: | 8.81% | ROA: | 5.06% | Short Interest: | 8.67M | Perf Year: | 4.60% |
| Cash/sh: | 7.66 | P/C: | 10.30 | EPS next 5Y: | 10.24% | ROE: | 21.70% | 52W Range: | 71.31 - 94.55 | Perf YTD: | 2.06% |
| Dividend Est.: | 0.13 (0.16%) | P/FCF: | 21.68 | EPS past 5Y: | -2.54% | ROI: | 9.34% | 52W High: | -16.54% | Beta: | 1.31 |
| Dividend TTM: | 0.12 (0.15%) | Quick Ratio: | 0.94 | Sales past 5Y: | 4.14% | Gross Margin: | 41.42% | 52W Low: | 10.66% | ATR (14): | 1.73 |
| Dividend Ex-Date: | Jan 14, 2025 | Current Ratio: | 1.19 | EPS Y/Y TTM: | 8.62% | Oper. Margin: | 14.56% | RSI (14): | 36.91 | Volatility: | 2.59% 1.93% |
| Employees: | 51000 | Debt/Eq: | 1.29 | Sales Y/Y TTM: | 1.42% | Profit Margin: | 8.56% | Recom: | 1.90 | Target Price: | 96.47 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 1.16 | EPS Q/Q: | 25.06% | Payout: | 3.97% | Rel Volume: | 3.42 | Prev Close: | 77.43 |
| Sales Surprise: | -0.11% | EPS Surprise: | 8.31% | Sales Q/Q: | 0.85% | Earnings: | Oct 30 BMO | Avg Volume: | 3.27M | Price: | 78.91 |
| SMA20: | -3.06% | SMA50: | -6.94% | SMA200: | -6.24% | Undervalued: 22.25% | Volume: | 11,164,311 | Change: | 1.91% | |
Graham Classic formula value: 94.98
(P/E=8 * 1g) Min value: 59.78
(current P/E * 2g) Max value: 137.95
Average value: 97.57
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company's history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.